')">
Market access update
Exploring the challenges for pricing and reimbursement of high-cost combination therapies
Gain market access insight from payer and pricing experts from across the EU into:
- the reimbursement mechanisms for combination products
- the access challenges these mechanisms present for new innovative combinations
- the scope for potential solutions
- the policy direction in France, Germany, and the UK
